157 related articles for article (PubMed ID: 18779380)
1. Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport.
Moos MP; Mewburn JD; Kan FW; Ishii S; Abe M; Sakimura K; Noguchi K; Shimizu T; Funk CD
FASEB J; 2008 Dec; 22(12):4352-62. PubMed ID: 18779380
[TBL] [Abstract][Full Text] [Related]
2. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
3. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Hui Y; Cheng Y; Smalera I; Jian W; Goldhahn L; Fitzgerald GA; Funk CD
Circulation; 2004 Nov; 110(21):3360-6. PubMed ID: 15545522
[TBL] [Abstract][Full Text] [Related]
4. The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy.
Barajas-Espinosa A; Ni NC; Yan D; Zarini S; Murphy RC; Funk CD
FASEB J; 2012 Mar; 26(3):1100-9. PubMed ID: 22131271
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes.
Di Gennaro A; Carnini C; Buccellati C; Ballerio R; Zarini S; Fumagalli F; Viappiani S; Librizzi L; Hernandez A; Murphy RC; Constantin G; De Curtis M; Folco G; Sala A
FASEB J; 2004 May; 18(7):842-4. PubMed ID: 15001558
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses.
Maekawa A; Austen KF; Kanaoka Y
J Biol Chem; 2002 Jun; 277(23):20820-4. PubMed ID: 11932261
[TBL] [Abstract][Full Text] [Related]
7. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
9. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
10. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.
Meliton AY; Munoz NM; Leff AR
J Allergy Clin Immunol; 2007 Dec; 120(6):1316-23. PubMed ID: 17904626
[TBL] [Abstract][Full Text] [Related]
11. Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury.
Ni NC; Ballantyne LL; Mewburn JD; Funk CD
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):321-30. PubMed ID: 24285579
[TBL] [Abstract][Full Text] [Related]
12. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cysteinyl leukotriene 2 receptor expression and myocardial ischemia/reperfusion injury.
Moos MP; Funk CD
Trends Cardiovasc Med; 2008 Oct; 18(7):268-73. PubMed ID: 19232956
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of human cysteinyl leukotriene 1 receptor gene structure.
Woszczek G; Pawliczak R; Qi HY; Nagineni S; Alsaaty S; Logun C; Shelhamer JH
J Immunol; 2005 Oct; 175(8):5152-9. PubMed ID: 16210619
[TBL] [Abstract][Full Text] [Related]
16. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cysteinyl-leukotriene-1 receptor and human transitional cell carcinoma in bladder.
Matsuyama M; Funao K; Hayama T; Tanaka T; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Urology; 2009 Apr; 73(4):916-21. PubMed ID: 19167045
[TBL] [Abstract][Full Text] [Related]
18. Leukotrienes mediate 5-hydroxytryptamine-induced plasma extravasation in the rat knee joint via CysLT-type receptors.
Wang Y; Mitchell J; Sharma M; Gabriel A; Moriyama K; Palmer PP
Inflamm Res; 2004 Feb; 53(2):66-71. PubMed ID: 15021971
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene D4 stimulates the migration but not proliferation of endothelial cells mediated by the cysteinyl leukotriene cyslt(1) receptor via the extracellular signal-regulated kinase pathway.
Yuan YM; Fang SH; Qian XD; Liu LY; Xu LH; Shi WZ; Zhang LH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Sci; 2009 Feb; 109(2):285-92. PubMed ID: 19234368
[TBL] [Abstract][Full Text] [Related]
20. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
